Immune thrombocytopenia in a child with COVID-19: Is it the calm after the (cytokine) storm?
Pediatr Blood Cancer
.
2022 Jan;69(1):e29326.
doi: 10.1002/pbc.29326.
Epub 2021 Sep 7.
Authors
Giulia Ceglie
1
2
,
Maria Antonietta De Ioris
1
,
Stefania Mercadante
3
4
,
Nicole Olivini
3
,
Francesca Del Bufalo
1
,
Silvio Marchesani
3
4
,
Francesca Cocca
1
,
Emanuela Monteferrario
1
,
Emilia Boccieri
1
,
Jolanda Pianese
1
,
Giuseppe Palumbo
1
4
Affiliations
1
Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
2
PhD Program in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
3
University Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
4
Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
PMID:
34490996
PMCID:
PMC8661709
DOI:
10.1002/pbc.29326
No abstract available
Publication types
Case Reports
Letter
MeSH terms
COVID-19* / complications
Child
Cytokine Release Syndrome* / virology
Cytokines
Humans
Male
Purpura, Thrombocytopenic, Idiopathic* / virology
Substances
Cytokines